Association Between Insulin Resistance, Metabolic Syndrome and Its Components and Lung Cancer: a Systematic Review and Meta-analysis

Overview

Journal Diabetol Metab Syndr

Publisher Biomed Central

Specialty Endocrinology

Date 2024 Mar 12

PMID 38468310

Authors

Jingxuan Liu

Rui Wang

Song Tan

Xiaohu Zhao

Aihua Hou

Affiliations

Soon will be listed here.

Abstract

Background: A growing body of evidence points to the association between insulin resistance (IR), metabolic syndrome (MetS) and its components and lung cancer incidence, but remains controversial and unknown.

Methods: A systematic search was conducted through PubMed, Embase, Cochrane Library, the China National Knowledge Infrastructure (CNKI) and Wanfang databases for the corresponding studies. Each study reported the risk estimate and 95% confidence intervals (CI) for lung cancer, and a fixed effects model or random effects model was used for outcome.

Results: We included 31 publications involving 6,589,383 people with 62,246 cases of lung cancer. Diabetes mellitus (DM) (RR = 1.11, 95% CI 1.06-1.16, P = 0.000) and IR (RR = 2.35, 95% CI 1.55-3.58, P = 0.000) showed a positive association with lung cancer risk. BMI (RR = 0.66, 95% CI 0.54-0.81, P = 0.000) and HDL-C (RR = 0.88, 95% CI 0.79-0.97, P = 0.010) were negatively correlated with lung cancer. MetS(RR = 0.99, 95% CI 0.90-1.09, P = 0.801), TC (RR = 0.93, 95% CI 0.81-1.06, P = 0.274), TG (RR = 0.99, 95% CI 0.88-1.12,P = 0.884), LDL-C (RR = 1.01, 95% CI 0.87-1.16, P = 0.928), hypertension (RR = 1.01, 95% CI 0.88-1.15, P = 0.928), FBG (RR = 1.02, 95% CI 0.92-1.13, P = 0.677) and obesity (RR = 1.11, 95% CI 0.92-1.35, P = 0.280) were not associated with lung cancer.

Conclusion: Our study showed that the risk of lung cancer is correlated with DM, IR, BMI, and HDL-C. Timely control of these metabolic disorders may have a positive effect on preventing lung cancer. Trial registration Our study has been registered in the Prospective Register of Systematic Reviews (PROSPERO), ID: CRD42023390710.

Citing Articles

Insulin Resistance and Cancer.

Bloomgarden Z J Diabetes. 2025; 17(2):e70064.

PMID: 40008541 PMC: 11862885. DOI: 10.1111/1753-0407.70064.

[Progress in the Study of Mechanisms Clinically Relevant to Insulin Resistance  and Lung Cancer].

Chen X, Chen P Zhongguo Fei Ai Za Zhi. 2024; 27(10):755-762.

PMID: 39631832 PMC: 11629090. DOI: 10.3779/j.issn.1009-3419.2024.106.27.

Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank.

Yang C, Cheng W, Plum P, Koppe J, Gockel I, Thieme R J Cancer Res Clin Oncol. 2024; 150(8):399.

PMID: 39180548 PMC: 11344731. DOI: 10.1007/s00432-024-05919-8.

The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients.

Frak M, Grenda A, Krawczyk P, Kuznar-Kaminska B, Pazdrowski P, Kedra K BMC Cancer. 2024; 24(1):937.

PMID: 39090596 PMC: 11295594. DOI: 10.1186/s12885-024-12716-6.

References

Su F, Grijalva V, Navab K, Ganapathy E, Meriwether D, Imaizumi S . HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer. Mol Cancer Ther. 2012; 11(6):1311-9. PMC: 3374063. DOI: 10.1158/1535-7163.MCT-11-0905. View

Saisana M, Griffin S, May F . Insulin and the insulin receptor collaborate to promote human gastric cancer. Gastric Cancer. 2021; 25(1):107-123. PMC: 8732810. DOI: 10.1007/s10120-021-01236-y. View

Ko S, Yoon S, Kim D, Kim A, Kim E, Seo H . Metabolic Risk Profile and Cancer in Korean Men and Women. J Prev Med Public Health. 2016; 49(3):143-52. PMC: 4898898. DOI: 10.3961/jpmph.16.021. View

Karlstad O, Starup-Linde J, Vestergaard P, Hjellvik V, Bazelier M, Schmidt M . Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies. Curr Drug Saf. 2013; 8(5):333-48. PMC: 3899599. DOI: 10.2174/15680266113136660067. View

Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B . Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007; 30(3):561-7. DOI: 10.2337/dc06-0922. View

Wang H, Yan F, Cui Y, Chen F, Wang G, Cui W . Association between triglyceride glucose index and risk of cancer: A meta-analysis. Front Endocrinol (Lausanne). 2023; 13:1098492. PMC: 9877418. DOI: 10.3389/fendo.2022.1098492. View

Luo J, Chlebowski R, Wactawski-Wende J, Schlecht N, Tinker L, Margolis K . Diabetes and lung cancer among postmenopausal women. Diabetes Care. 2012; 35(7):1485-91. PMC: 3379607. DOI: 10.2337/dc11-2108. View

Palmiero P, Maiello M, Cecere A, Ciccone M . Metabolic syndrome and breast cancer: a dangerous association for postmenopausal women. Acta Biomed. 2021; 92(4):e2021177. PMC: 8477089. DOI: 10.23750/abm.v92i3.11335. View

Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G . Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006; 49(5):945-52. DOI: 10.1007/s00125-006-0207-6. View

10.

Lyu Z, Li N, Wang G, Feng X, Chen S, Su K . Independent and joint associations of blood lipids and lipoproteins with lung cancer risk in Chinese males: A prospective cohort study. Int J Cancer. 2018; 144(12):2972-2984. DOI: 10.1002/ijc.32051. View

11.

Loftfield E, Freedman N, Lai G, Weinstein S, McGlynn K, Taylor P . Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes. Cancer Prev Res (Phila). 2016; 9(11):866-874. PMC: 5093066. DOI: 10.1158/1940-6207.CAPR-16-0141. View

12.

Chen L, Zhang L, Xian G, Lv Y, Lin Y, Wang Y . 25-Hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells. Biochem Biophys Res Commun. 2017; 484(4):857-863. DOI: 10.1016/j.bbrc.2017.02.003. View

13.

Ding J, Tang J, Chen X, Men H, Luo W, Du Y . Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus. Asian Pac J Cancer Prev. 2013; 14(10):5675-80. DOI: 10.7314/apjcp.2013.14.10.5675. View

14.

Johnson J, Bowker S, Richardson K, Marra C . Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia. 2011; 54(9):2263-71. DOI: 10.1007/s00125-011-2242-1. View

15.

Kabat G, Kim M, Chlebowski R, Khandekar J, Ko M, McTiernan A . A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18(7):2046-53. PMC: 6204126. DOI: 10.1158/1055-9965.EPI-09-0235. View

16.

Li S, Wang Z, Huang J, Fan J, Du H, Liu L . Systematic review of prognostic roles of body mass index for patients undergoing lung cancer surgery: does the 'obesity paradox' really exist?. Eur J Cardiothorac Surg. 2017; 51(5):817-828. DOI: 10.1093/ejcts/ezw386. View

17.

Liu J, Yang X, Liu X, Xu Y, Huang H . Predictors of Readmission After Pulmonary Resection in Patients With Lung Cancer: A Systematic Review and Meta-analysis. Technol Cancer Res Treat. 2022; 21:15330338221144512. PMC: 9806362. DOI: 10.1177/15330338221144512. View

18.

Kira S, Ito C, Fujikawa R, Misumi M . Increased cancer mortality among Japanese individuals with hyperinsulinemia. Metabol Open. 2020; 7:100048. PMC: 7424784. DOI: 10.1016/j.metop.2020.100048. View

19.

Hernandez-Perez J, Torres-Sanchez L, Hernandez-Alcaraz C, Lopez-Carrillo L, Rodriguez-Covarrubias F, Vazquez-Salas R . Metabolic Syndrome and Prostate Cancer Risk: A Population Case-control Study. Arch Med Res. 2022; 53(6):594-602. DOI: 10.1016/j.arcmed.2022.07.003. View

20.

Chodick G, Heymann A, Rosenmann L, Green M, Flash S, Porath A . Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control. 2010; 21(6):879-87. DOI: 10.1007/s10552-010-9515-8. View